Literature DB >> 25141284

Molecular detection of Mayaro virus during a dengue outbreak in the state of Mato Grosso, Central-West Brazil.

Nayara Zuchi1, Letícia Borges da Silva Heinen1, Marcelo Adriano Mendes dos Santos2, Fernanda Carla Pereira1, Renata Dezengrini Slhessarenko1.   

Abstract

Mayaro virus (MAYV) is frequently reported in Pan-Amazonia. The aim of this study was to investigate the circulation of alphaviruses during a dengue outbreak in the state of Mato Grosso, Brazil. Serum samples from dengue-suspected patients were subjected to multiplex semi-nested reverse transcriptase polymerase chain reaction for 11 flaviviruses and five alphaviruses, to nucleotide sequencing and to viral isolation. MAYV was detected in 15 (2.5%) of 604 patients. Twelve were co-infected with dengue virus 4, which was isolated from 10 patients. The molecular detection of MAYV in dengue-suspected patients suggests that other arboviruses may be silently circulating during dengue outbreaks in Brazil.

Entities:  

Mesh:

Year:  2014        PMID: 25141284      PMCID: PMC4238776          DOI: 10.1590/0074-0276140108

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


Mayaro virus (MAYV) is an arbovirus belonging to the Semliki Forest antigenic serocomplex of the Al ph a v i rus genus in the Togaviridae family (Vasconcelos et al. 1998). MAYV was first isolated from rural workers in Trinidad in 1954; since then, viral isolation and serologic response have been reported in South America (Anderson et al. 1957, Talarmin et al. 1998, Vasconcelos et al. 1998, Forshey et al. 2010). MAYV is believed to be maintained in sylvatic and rural cycles in tropical South America involving primarily Ha emagogus janthinomys mosquitoes as vectors and non-human primates and birds as primary and secondary hosts, respectively. Human infections are generally sporadic and accidental (Abad-Franch et al. 2012). Mayaro fever is a mild, self-limited acute febrile illness characterised by transient viraemia lasting three-five days, which is accompanied by rash, fever, malaise, headache, eye pain, myalgia and arthralgia that may last for several days or weeks (Pinheiro et al. 1981, Azevedo et al. 2009). In South America, MAYV circulates primarily in the Amazon Region. The non-specific clinical presentation of Mayaro fever is often confused with that of dengue fever (Pinheiro et al. 1981, Azevedo et al. 2009), which is widespread and occurs frequently in Brazil. Laboratory diagnosis has been directed toward infection with this flavivirus, which could prevent the identification of other important arboviruses eventually circulating in the population, including those never before reported in Brazil. In this regard, molecular investigations are useful for population screening and arboviral differential diagnosis. In Brazil, MAYV outbreaks have been reported periodically in the North Region since the 1950s, including in the states of Pará (PA) and Amazonas (AM) (Azevedo et al. 2009, Nunes et al. 2009, Mourão et al. 2012). In contrast, Mayaro fever has not often been reported in other regions of the country. There are, however, a few reports in Central-West Brazil, including the states of Goiás and Mato Grosso do Sul (MS) (Pinheiro et al. 1981, Vasconcelos et al. 1998, Coimbra et al. 2007). In the state of Mato Grosso (MT), the largest in the region, the only report of MAYV circulation involved serological evidence among native Brazilian Xavante Indians in 1968 (Neel et al. 1968). Recently, MAYV was reported in urban/periurban areas and was associated with nocturnal transmission cycles in Manaus, AM, highlighting concerns about the potential urbanisation of Mayaro fever in Brazil (Abad-Franch et al. 2012, Mourão et al. 2012). Considering there are no recent data demonstrating MAYV circulation in MT and given that alphavirus infections - including Mayaro fever - are often confused with dengue fever, the main objective of the present study was to conduct a molecular investigation for alphaviruses in patients during a large dengue fever outbreak. Patients presenting with acute febrile illness for no more than five days and who sought medical attention at health-care facilities in 20 MT municipalities between October 2011-July 2012 were included in the study. Research involving humans had been pre-approved by the institutional Ethical Committee (Júlio Muller University Hospital, protocol 100/2011). The 604 acute serum samples obtained were subjected to RNA extraction using a commercial kit (QIAamp® Viral RNA Mini Kit, Qiagen Inc) in accordance with the manufacturer’s instructions. The extracted RNA was subjected to a duplex semi-nested reverse transcriptase polymerase chain reaction (PCR) for an NS5 gene region of flaviviruses and an NSP1 gene region of alphaviruses. This was followed by species-specific multiplex semi-nested PCR for MAYV, Aura virus, Eastern, Western and Venezuelan equine encephalitis viruses and a species-specific multiplex semi-nested PCR for dengue virus (DENV) serotypes and seven other flaviviruses (Bronzoni et al. 2005). Fifteen out of 604 patients (2.5%) were positive for MAYV RNA, with the breakdown in Cuiabá (9/15), Várzea Grande (3/15), Sorriso (2/15) and Nossa Senhora do Livramento (1/15). All these cities are located in the Cerrado biome (Fig. 1). Samples positive for MAYV RNA were tested at least twice in independent reactions. Single nested-PCR amplicons obtained with the same primers for MAYV NSP1 gene (270 nt) were sequenced (3500 Genetic Analyzer, Applied Biosystems, USA) and analysed using Geneious R7 (v.7.0.7, USA) and Basic Local Alignment Search Tool (PubMed) to confirm amplification. The sequences were deposited at GenBank and PubMed. Positive samples were also subjected to viral isolation using Vero and C6/36 cells (Figueiredo et al. 1992).
Fig. 1

: distribution of patients with acute febrile illness from the state of Mato Grosso (MT), Brazil, investigated for arbovirus during a dengue outbreak in 2012. Cities with patients positive for Mayaro virus (MAYV) RNA and/or dengue virus 4 (DENV-4) are identified. Brazilian states: Amazonas (AM), Mato Grosso do Sul (MS), Pará (PA), Rondônia (RO), Tocantins (TO).

The MAYV-positive samples were collected between January-May 2012, a period that offers environmental conditions favourable to vector proliferation and arboviruses activity. Of the 15 patients positive for MAYV RNA, 12 (80%) were also positive for DENV-4 RNA; two patients from Cuiabá and one from Sorriso (20%) were positive only for MAYV. DENV-4 was isolated in C6/36 cells from 10 out of the 12 co-infected patients. However, attempts at MAYV isolation were unsuccessful. Possible explanations are the limitations described for MAYV recovery during outbreaks from the sera of human hosts, namely low viral titres, transient viraemia and viral RNA degradation (Talarmin et al. 1998, Vasconcelos et al. 1998, Coimbra et al. 2007, Azevedo et al. 2009, Mourão et al. 2012). The 12 co-infections identified most likely occurred due to the large outbreak of dengue observed in MT in 2012, when 44,814 cases were reported, with 96.2% being attributed to the recently introduced DENV-4 and 3.8% to DENV-1 (MS 2012). Cuiabá presented the majority of the cases, with 10,742 documented cases, followed by Várzea Grande, with 3,133 documented cases (SES-MT 2013). The patients enrolled in this study sought medical attention after developing acute febrile symptoms for five or fewer days. As MAYV infections are frequently accompanied by transient viraemia (Vasconcelos et al. 1998), this aspect combined with the absence of routine differential diagnosis may contribute to the silent circulation of MAYV during dengue outbreaks. The nucleotide sequences obtained from MAYV-positive patients presented 80-100% identity with sequences from the reference strain Brazil and other MAYV isolates obtained from human and arthropods in different periods, such as BeH343148 isolated in PA (1978) and Uruma from Bolivia (1955), both belonging to genotype D, and BeAr505411 from PA (1991), which is classified as genotype L (Table).
TABLE

Clinical aqnd epidemiological data of patients with acute febrile illness for fewer than five days from the state of Mato Grosso, Brazil, positive for Mayaro virus (MAYV) RNA or co-infected with dengue virus 4 (DENV-4) - 2012

Patient n (age)SexOccupationCity of originClinical signs and simptoms and history of previous similar diseaseRT-PCRGenBank accessions
9 (43)FHousekeeperCuiabáHyperthermia, myalgia, arthralgia, nausea, petechiae, pruritus, retrorbital painDENV-4/MAYVKJ682316
12 (10)FStudentNossa Senhora do LivramentoHyperthermia, myalgia, headache, retrorbital painDENV-4/MAYVKJ879255
20 (19)MSalesmanVárzea GrandeHyperthermia, myalgia, headache, prostation, emesisDENV-4/MAYVKJ713282
22 (40)FNurseVárzea GrandeHyperthermia, myalgia, prostation, retrorbital painDENV-4/MAYVKJ879258
127 (16)MStudentCuiabáHyperthermia, myalgia, headache, retrorbital painDENV-4/MAYVNA
147 (48)FSeamstressVárzea GrandeHyperthermia, myalgia, arthralgia, headache, retrorbital pain, petechiaeDENV-4/MAYVKJ739869
220 (17)MSalesmanCuiabáHyperthermia, headache, dizziness, nauseaDENV-4/MAYVNA
230 (20)MBricklayerCuiabáHyperthermia, myalgia, headache, retrorbital pain, emesisDENV-4/MAYVKJ879253
246 (18)MInmateSorrisoHyperthermia, myalgia, arthralgia, headache, retrorbital pain, nauseaMAYVKJ879333
301 (42)MSalesmanCuiabáHyperthermia, myalgia, arthralgia, retrorbital painMAYVKJ879259
305 (20)MDeliverymanCuiabáHyperthermia, headache, retrorbital painDENV-4/MAYVKJ879254
306 (20)FAuxiliaryCuiabáHyperthermia, myalgia: dengue infectionMAYVKJ879256
308 (16)FTelemarketing attendantCuiabáHyperthermia, headache, prostation, retrorbital painDENV-4/MAYVKJ879257
322 (21)FReceptionistCuiabáHyperthermia, headache, prostation, retrorbital pain, anorexiaDENV-4/MAYVKJ870987
618 (33)MSalesmanSorrisoHyperthermia, headache, myalgiaDENV-4/MAYVNA

F: female; M: male; NA: not available; RT-PCR: reverse transcriptase polymerase chain reaction.

Most of the MAYV-positive patients (14/15; 92.7%) were 15-59 years old and both sexes were affected equally (Fig. 2). All positive patients described themselves as urban residents (Fig. 1), without a recent history of travel or access to rural or sylvatic areas. This indicates that MAYV may not be restricted to sylvatic or rural cycles in MT, as observed in Manaus, AM (Abad-Franch et al. 2012, Mourão et al. 2012). Mayaro prevalence is generally higher among adult male with occupations related to sylvatic or rural environments (Azevedo et al. 2009). However, no differences regarding gender, age (Fig. 2) or occupation (Table) were observed in this study. These findings may corroborate the occurrence of urban transmission cycles. However, it is worth noting that is difficult to determine the boundaries between urban and rural/sylvatic areas in some cities in Central-West Brazil. Thus, further studies focused on entomological surveillance are necessary to evaluate MAYV potential transmission cycles in MT.
Fig. 2

: prevalence of Mayaro virus in febrile patients from municipalities of the state of Mato Grosso, Brazil, during a dengue outbreak in 2012, according to patient age (A) and gender (B).

F: female; M: male; NA: not available; RT-PCR: reverse transcriptase polymerase chain reaction. The patients who were positive only for MAYV RNA presented hyperthermia, myalgia, arthralgia, headache, retro-orbital pain and nausea (Table). Those also positive for DENV-4 RNA reported hyperthermia (100%), retro-orbital pain (75%), headache (83.3%), myalgia (66.6%), prostration (33.3%), arthralgia (16.6%), nausea (16.6%), emesis (16.6%), petechiae (16.6%) and anorexia (8.3%) (Table). The detection of DENV and MAYV highlights the importance of differential diagnosis in patients with suspected dengue fever. Chikungunya virus (CHIKV), another alphavirus of the same serocomplex as MAYV and producing clinical infection similar to dengue fever, was recently introduced in the Caribbean. Similar to DENV, CHIKV has lost the requirement for sylvatic amplification, producing extensive urban epidemics involving Aedes aegypti and Aedes albopictus as vectors (Enserink 2014). Considering that Central America is a common route for DENV serotype introduction into Brazil and these vector species are widely dispersed in the country, there is a concern about the introduction and rapid spread of CHIKV in Brazil. H. janthinomys, the main vector of MAYV, predominates in sylvatic areas. However, natural infection by MAYV of Psorophora and Mansonia species and experimental transmission by Aedes and Culex species has been demonstrated (Aitken et al. 1960, Galindo & Srihongse 1967, Smith & Francy 1991). Species of Culicidae potentially associated with MAYV transmission are currently being investigated in the urban area of Cuiabá, where the vast majority of MAYV-positive patients were identified. Whether the co-infections by DENV-4 and MAYV identified in this study are the result from exposure to co-infected vector mosquitoes or to multiple infected vector species in a short period is unknown. Competitive suppression of CHIKV replication in C6/36 cells during co-infection occurs when DENV is inoculated in higher titres (Potiwat et al. 2011). However, studies involving co-infections by DENV and alphaviruses, including MAYV, in vector species are lacking. MAYV was previously reported in neighbouring states, including virus isolation from a patient regressing from Camapuã, MS (Coimbra et al. 2007) and serologic response indicating recent infection in residents from cities in PA affected by the Cuiabá-Santarém Highway (Nunes et al. 2009). The present study suggests human acute infection by MAYV in MT. Entomological and epidaemiological surveillance strategies are necessary to confirm the current circulation of the virus in the state. The molecular detection of MAYV in febrile patients suspected of having dengue suggests that other arboviruses may be silently circulating during dengue outbreaks in MT. Our findings also point to the necessity of differential diagnoses to detect future introductions of arboviruses associated with dengue-like illness, but not previously reported in the country, such as CHIKV, during dengue fever outbreaks.
  17 in total

1.  Mayaro virus isolated from a Trinidadian mosquito, Mansonia venezuelensis.

Authors:  T H AITKEN; W G DOWNS; C R ANDERSON; L SPENCE; J CASALS
Journal:  Science       Date:  1960-04-01       Impact factor: 47.728

2.  Infectious diseases. Crippling virus set to conquer Western Hemisphere.

Authors:  Martin Enserink
Journal:  Science       Date:  2014-05-16       Impact factor: 47.728

3.  Mayaro fever in the city of Manaus, Brazil, 2007-2008.

Authors:  Maria Paula Gomes Mourão; Michele de Souza Bastos; Regina Pinto de Figueiredo; João Bosco Lima Gimaque; Elizabeth dos Santos Galusso; Valéria Munique Kramer; Cintia Mara Costa de Oliveira; Felipe Gomes Naveca; Luiz Tadeu Moraes Figueiredo
Journal:  Vector Borne Zoonotic Dis       Date:  2011-09-16       Impact factor: 2.133

4.  Competitive suppression between chikungunya and dengue virus in Aedes albopictus c6/36 cell line.

Authors:  Rutcharin Potiwat; Narumon Komalamisra; Usavadee Thavara; Apiwat Tawatsin; Padet Siriyasatien
Journal:  Southeast Asian J Trop Med Public Health       Date:  2011-11       Impact factor: 0.267

5.  [Arbovirus eco-epidemiology in the area affected by the Cuiabá-Santarém Highway (BR-163), Pará State, Brazil].

Authors:  Marcio Roberto Teixeira Nunes; Taciana Fernandes Souza Barbosa; Lívia Medeiros Neves Casseb; Joaquim Pinto Nunes Neto; Nazaré de Oliveira Segura; Hamilton Antônio de Oliveira Monteiro; Eliana Vieira Pinto; Samir Mansour Casseb; Jannifer de Oliveira Chiang; Lívia Caricio Martins; Daniele Barbosa de Almeida Medeiros; Pedro Fernando da Costa Vasconcelos
Journal:  Cad Saude Publica       Date:  2009-12       Impact factor: 1.632

6.  Mayaro virus: imported cases of human infection in São Paulo State, Brazil.

Authors:  Terezinha Lisieux M Coimbra; Cecília L S Santos; Akemi Suzuki; Selma M C Petrella; Ivani Bisordi; Adélia H Nagamori; Antonia T Marti; Raimundo N Santos; Danya M Fialho; Shirlene Lavigne; Marcia R Buzzar; Iray M Rocco
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2007 Jul-Aug       Impact factor: 1.846

7.  Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007.

Authors:  Brett M Forshey; Carolina Guevara; V Alberto Laguna-Torres; Manuel Cespedes; Jorge Vargas; Alberto Gianella; Efrain Vallejo; César Madrid; Nicolas Aguayo; Eduardo Gotuzzo; Victor Suarez; Ana Maria Morales; Luis Beingolea; Nora Reyes; Juan Perez; Monica Negrete; Claudio Rocha; Amy C Morrison; Kevin L Russell; Patrick J Blair; James G Olson; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

8.  Mayaro virus: a new human disease agent. II. Isolation from blood of patients in Trinidad, B.W.I.

Authors:  C R ANDERSON; W G DOWNS; G H WATTLEY; N W AHIN; A A REESE
Journal:  Am J Trop Med Hyg       Date:  1957-11       Impact factor: 2.345

9.  Mayaro fever virus, Brazilian Amazon.

Authors:  Raimunda S S Azevedo; Eliana V P Silva; Valéria L Carvalho; Sueli G Rodrigues; Joaquim P Nunes-Neto; Hamilton Monteiro; Victor S Peixoto; Jannifer O Chiang; Márcio R T Nunes; Pedro F C Vasconcelos
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

10.  Mayaro virus infection in amazonia: a multimodel inference approach to risk factor assessment.

Authors:  Fernando Abad-Franch; Gustavo H Grimmer; Vanessa S de Paula; Luiz T M Figueiredo; Wornei S M Braga; Sérgio L B Luz
Journal:  PLoS Negl Trop Dis       Date:  2012-10-11
View more
  35 in total

1.  Rate of exposure to Mayaro virus (MAYV) in Brazil between 1955 and 2018: a systematic review and meta-analysis.

Authors:  William Gustavo Lima; Rosângela Santos Pereira; Waleska Stephanie da Cruz Nizer; Júlio César Moreira Brito; Isabella Piassi Godói; Valbert Nascimento Cardoso; Simone Odília Antunes Fernandes; Jaqueline Maria Siqueira Ferreira
Journal:  Arch Virol       Date:  2021-01-07       Impact factor: 2.574

2.  Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.

Authors:  Marcílio Jorge Fumagalli; William Marciel de Souza; Marília Farignoli Romeiro; Michell Charles de Souza Costa; Renata Dezengrini Slhessarenko; Luiz Tadeu Moraes Figueiredo
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

3.  Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.

Authors:  Marcilio Jorge Fumagalli; William Marciel de Souza; Luiza Antunes de Castro-Jorge; Renan Villanova Homem de Carvalho; Ítalo de Araújo Castro; Luiz Gustavo Nogueira de Almeida; Silvio Roberto Consonni; Dario Simões Zamboni; Luiz Tadeu Moraes Figueiredo
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

4.  Chemical composition and anti-Mayaro virus activity of Schinus terebinthifolius fruits.

Authors:  Tiago S Salles; Marcelo D F Meneses; Kristie A Yamamoto; Thayane E Sá-Guimarães; Lucio Ayres Caldas; Jessica H S Silva; Polianna da Silva Ferreira; Ana Claudia F Amaral; José A Ventura; Renata Campos Azevedo; Ricardo M Kuster; Márcia R Soares; Davis F Ferreira
Journal:  Virusdisease       Date:  2021-06-04

5.  Mayaro Virus: The Potential Role of Microbiota and Wolbachia.

Authors:  Thiago Nunes Pereira; Fabiano Duarte Carvalho; Jerônimo Nunes Rugani; Vanessa Rafaela de Carvalho; Jaqueline Jarusevicius; Jayme A Souza-Neto; Luciano Andrade Moreira
Journal:  Pathogens       Date:  2021-04-27

6.  False-negative dengue cases.

Authors:  Sim Sai Tin; Viroj Wiwanitkit
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

7.  Neutralising antibodies for Mayaro virus in Pantanal, Brazil.

Authors:  Alex Pauvolid-Corrêa; Raquel Soares Juliano; Zilca Campos; Jason Velez; Rita Maria Ribeiro Nogueira; Nicholas Komar
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-03       Impact factor: 2.743

8.  Mayaro virus and dengue virus 1 and 4 natural infection in culicids from Cuiabá, state of Mato Grosso, Brazil.

Authors:  Otacília Pereira Serra; Belgath Fernandes Cardoso; Ana Lúcia Maria Ribeiro; Fábio Alexandre Leal dos Santos; Renata Dezengrini Slhessarenko
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-01       Impact factor: 2.743

9.  Detection of Oropouche virus segment S in patients and inCulex quinquefasciatus in the state of Mato Grosso, Brazil.

Authors:  Belgath Fernandes Cardoso; Otacília Pereira Serra; Letícia Borges da Silva Heinen; Nayara Zuchi; Victor Costa de Souza; Felipe Gomes Naveca; Marcelo Adriano Mendes dos Santos; Renata Dezengrini Slhessarenko
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-09       Impact factor: 2.743

10.  Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays.

Authors:  Barbara W Johnson; Christin H Goodman; Kimberly Holloway; P Martinez de Salazar; Anne M Valadere; Michael A Drebot
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.